Major Depression Inventory (MDI)
Self-report depression scale covering the ICD-10 and DSM-IV depressive symptoms over the past 2 weeks: 12 questions, of which items 8 and 10 each have two parts and only the higher counts, so 10 item scores of 0–5 (total 0–50).
Score interpretation
MDI 0–20 — below threshold for depression diagnosis
→ Psychoeducation; monitor; lifestyle interventions; reassess if symptoms persist or worsen
MDI 21–25 — mild depression
→ Low-intensity interventions (guided self-help, CBT); consider antidepressant if persistent; active monitoring every 2 weeks
MDI 26–30 — moderate depression
→ Antidepressant therapy (Adults: SSRI first-line, sertraline 50 mg OD. Children: use a children's formulary.); psychological therapy (CBT); consider psychiatry input; safety assessment
MDI ≥31 — severe depression
→ Urgent psychiatry referral; pharmacotherapy with close monitoring; assess suicide risk (C-SSRS); consider hospitalisation if high risk; combination pharmacotherapy + psychotherapy
Interpretation bands for the MDI. Apply clinical judgement and local guidance.
References
- Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord. 2001;66(2-3):159–164.
- Bech P, Timmerby N, Martiny K, Lunde M, Soendergaard S. Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity. BMC Psychiatry. 2015;15:190.
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.